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PCardiac Resynchronization
Acute Effects of Initiation and Withdrawal of
Cardiac Resynchronization Therapy on Papillary
Muscle Dyssynchrony and Mitral Regurgitation
Claudia Ypenburg, MD,* Patrizio Lancellotti, MD, PHD,† Laurens F. Tops, MD,*
Gabe B. Bleeker, MD,* Eduard R. Holman, MD, PHD,* Luc A. Piérard, MD, PHD,†
Martin J. Schalij, MD, PHD,* Jeroen J. Bax, MD, PHD*
Leiden, the Netherlands; and Liege, Belgium
Objectives The purpose of this study was to evaluate the relationship between dyssynchrony involving the mitral valve appa-
ratus and the acute improvement in mitral regurgitation (MR) after cardiac resynchronization therapy (CRT). The
effect of interruption of CRT at 6 months’ follow-up on dyssynchrony and MR was also evaluated.
Background Mitral regurgitation may improve acutely after CRT, but the precise mechanism is not fully understood.
Methods Out of 63 consecutive patients with baseline MR, 25 patients showed an acute reduction in MR severity immedi-
ately after CRT. This selected group of 25 patients (age 68  10 years, left ventricular ejection fraction 23 
8%) was evaluated in the current study. Echocardiography including speckle tracking strain analysis was per-
formed at baseline, after CRT initiation, and during interruption of CRT at 6 months’ follow-up to study the rela-
tionship between dyssynchrony between the papillary muscles and severity of MR.
Results According to the inclusion criteria, all patients showed an immediate improvement in MR after CRT (vena con-
tracta width decreased from 0.54  0.15 cm to 0.39  0.13 cm; p  0.001), accompanied by an improvement
in mitral deformation indexes. Furthermore, dyssynchrony between the papillary muscles decreased from 169 
69 ms to 25  26 ms (p  0.001). Importantly, these beneficial effects were maintained at 6 months’ follow-
up, but acute loss of resynchronization (from 26  28 ms to 134  51 ms; p  0.001) was observed after inter-
ruption of CRT, with an acute recurrence of MR and worsening in mitral deformation indexes.
Conclusions Cardiac resynchronization therapy can acutely reduce MR in patients with dyssynchrony involving the papillary
muscles; interruption of CRT at 6 months’ follow-up, however, resulted in acute loss of resynchronization with
recurrence of MR. (J Am Coll Cardiol 2007;50:2071–7) © 2007 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.019p
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cecent studies have demonstrated that cardiac resynchroni-
ation therapy (CRT) may acutely improve functional
itral regurgitation (MR) (1–3). However, the exact mech-
nism underlying the reduction in MR after CRT remains
nclear. Preliminary results suggest that the acute improve-
ent in MR may be related to improved coordination of
apillary muscle contraction (2).
In this context, we hypothesized that patients with
yssynchrony between the anterior and posterior papillary
uscles (APM-PPM dyssynchrony) will exhibit an acute
eduction in MR after CRT, owing to resynchronized
rom the *Department of Cardiology, Leiden University Medical Center, Leiden, the
etherlands; and the †Department of Cardiology, University Hospital Sart Tilman,
iege, Belgium. Supported by the Dutch Heart Foundation, grant no. 2002B109.
ohn Gorscan III, MD, FACC, served as Guest Editor for this article.f
Manuscript received April 20, 2007; revised manuscript received August 14, 2007,
ccepted August 20, 2007.apillary muscle contraction. Furthermore, it was hypothe-
ized that deactivating CRT after 6 months would cause loss
f resynchronization and acute recurrence of MR.
Accordingly, the study population consisted of selected
atients with moderate to severe MR who showed an
mmediate reduction in MR after CRT initiation. Extensive
chocardiographic evaluations were performed, including
peckle tracking radial strain analysis, to assess APM-PM
yssynchrony. Patients were evaluated before and immedi-
tely after CRT and again evaluated after 6 months with
RT on and off.
ethods
atients and study protocol. Between January 2005 and
uly 2006, 186 patients received a CRT device according to the
urrent guidelines: New York Heart Association (NYHA)
unctional class III or IV, depressed left ventricular (LV)
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and wide QRS complex (120
ms) (4). Sixty-three of these pa-
tients had significant MR at base-
line, with 25 patients showing an
acute improvement in MR severity
acutely after CRT initiation.
These 25 patients formed the fo-
cus of the current study.
The study protocol included
echocardiography at baseline, the
day after implantation, and at 6
months’ follow-up. After data
acquisition at 6 months’ follow-
up, CRT was interrupted to per-
form echocardiography during
intrinsic conduction or in right
ventricular pacing in patients with-
out intrinsic conduction. Further-
more, assessment of clinical status
was performed at baseline and af-
ter 6 months of CRT.
Echocardiography. All patients
underwent standard transtho-
acic 2-dimensional (2D) echocardiography, including
uantification of MR, LV function, global and local LV
emodeling, assessment of mitral valve deformation indexes,
nd speckle tracking strain analysis to assess APM-PPM
yssynchrony. All echocardiographic studies were per-
ormed the day before implantation, the day after implan-
ation, and at 6 months’ follow-up with CRT on and off.
he CRT device was turned off for 5 min before the
cquisition started. Patients were imaged in the left lateral
ecubitus position using a commercially available system
Vingmed Vivid 7, General Electric-Vingmed, Milwaukee,
isconsin). Images were obtained using a 3.5-MHz trans-
ucer at a depth of 16 cm in the parasternal and apical views
standard long-axis and 2- and 4-chamber images). Stan-
ard 2D and color Doppler data, triggered to the QRS
omplex, were saved in cine-loop format. For each measure-
ent, 3 cardiac cycles were averaged. Investigators were
ot blinded for the pacemaker settings.
uantification of MR and mitral deformation indexes.
he severity of MR was measured from the apical
-chamber view, by measuring the width of the vena
ontracta (5). Left atrial (LA) area and regurgitant jet area
ere measured by planimetry from the apical 4-chamber
iew, allowing calculation of the ratio of regurgitant jet area
o LA area (6). The severity of MR was graded as mild
vena contracta width 0.3 cm, LA area 4 cm2, or jet
rea/LA area 20%), moderate (vena contracta width 0.3
m to 0.7 cm, jet area/LA area 20% to 40%) or severe (vena
ontracta width 0.7 cm, jet area/LA area 40%) as
ecommended by the American College of Cardiology/
Abbreviations
and Acronyms
APM  anterior papillary
muscle
APM-PPM dyssynchrony 
dyssynchrony between the
anterior and posterior
papillary muscles
CRT  cardiac
resynchronization therapy
dP/dt  maximal rate of
left ventricular systolic
pressure increase
LA  left atrial
LV  left ventricular
NYHA  New York Heart
Association
PPM  posterior papillary
muscle
PPM-fibrosa  distance
between the posterior
papillary muscle head and
the intervalvular fibrosamerican Heart Association 2006 guidelines (6,7). IThe maximal rate of LV systolic pressure increase (dP/dt)
as estimated from the steepest rising segment on the
ontinuous-wave Doppler regurgitant signal (8). The val-
ular tenting area was obtained from the parasternal long-
xis view at mid-systole and was measured as the area
nclosed between the annular plane and mitral leaflets.
isplacement of mitral coaptation (coaptation height) to-
ard the LV apex was measured by the distance between
eaflet coaptation and the mitral annulus plane in the apical
-chamber view. Mitral annulus diameter was measured at
nd-systole and -diastole in the 4-chamber view. Annular
ontraction was calculated as: (end-diastolic diameter  end-
ystolic diameter)/end-diastolic diameter (9).
obal and local LV remodeling. The LV volumes (end-
iastolic and end-systolic) and ejection fraction were calcu-
ated from the conventional apical 2- and 4-chamber im-
ges, using the biplane Simpson technique (10). The
istance between the posterior papillary muscle head and
he intervalvular fibrosa (PPM-fibrosa) in the long-axis view
easured the apical displacement of the PPM (9).
peckle tracking strain analysis. Radial strain was as-
essed on LV short-axis images at the papillary muscle level,
sing speckle tracking analysis (11–13). Time-strain curves
or all of the 6 LV segments (septal, anteroseptal, anterior,
osterior, lateral, and inferior) were constructed. The seg-
ents adjacent to the papillary muscles were noted (Fig. 1).
eak radial strain and time from QRS onset to peak radial
train for the LV segments were obtained, and the severity
f APM-PPM dyssynchrony could be determined (Fig. 2).
adial strain measurements were reproducible and showed
inimal variability (interobserver correlation coefficient r 
.94; intraobserver correlation coefficient r  0.96).
RT implantation. A coronary sinus venogram was ob-
ained using balloon catheter, followed by the insertion of
he LV pacing lead. An 8-F guiding catheter was used to
osition the LV lead (Easytrak 4512-80, Guidant Corp., St.
aul, Minnesota, or Attain-SD 4189, Medtronic, Minne-
polis, Minnesota) in the coronary sinus. The preferred
osition was a lateral or posterolateral vein (14). The right
trial and ventricular leads were positioned conventionally.
ll leads were connected to a dual chamber biventricular
mplantable cardioverter-defibrillator (Contak Renewal II
r H195, Guidant Corp., or Insync III or Insync Sentry,
edtronic).
linical evaluation at 6 months’ follow-up. Clinical eval-
ation was performed before implantation and after 6
onths of CRT. The NYHA functional class was used to
valuate heart failure symptoms and scored by an indepen-
ent physician who was blinded to all other patient data.
uality-of-life score was assessed using the Minnesota
iving with Heart Failure Questionnaire (15). Exercise
olerance was assessed using the 6-min walk test (16). In all
f the patients, QRS duration was measured from the
urface ECG using the widest QRS complex from the leads
I, V1, and V6, at baseline and after implantation.
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November 20, 2007:2071–7 Reduction in MR After CRTtatistical analysis. Continuous variables are expressed as
ean  SD. Categoric data are summarized as frequencies
nd percentages.
Clinical parameters were assessed at baseline and at 6
onths’ follow-up. Comparison of these data during
ollow-up was performed with the paired student t test
Figure 1 Example of Position of the Papillary Muscles
Short-axis view of the left ventricle (LV) at the level of the papillary muscles,
with reconstruction of the 6 LV segments. In this patient, the anterior papillary
muscle (APM) was located adjacent to the lateral LV segment (green) and the
posterior papillary muscle (PPM) was located adjacent to the inferior LV seg-
ment (dark blue).
Figure 2 Position of the Papillary Muscles
The anterior papillary muscle (APM) was located adjacent to the lateral (LAT)
left ventricular (LV) segment in 18 patients (72%) and adjacent to the anterior
(ANT) LV segment in 7 patients (28%); the posterior papillary muscle (PPM)
was located adjacent to the inferior (INF) LV segment in 22 patients (88%) and
adjacent to the posterior (POST) LV segment in 3 patients (12%).pcontinuous variables) and the McNemar test (NYHA
unctional class, MR severity). A p value of 0.05 was
onsidered to be statistically significant.
All of the echocardiographic studies were performed the
ay before implantation, the day after implantation, and at
months’ follow-up with CRT on and off. Comparison of
hese data during follow-up was performed by applying the
tatistical tests mentioned. Baseline parameters were com-
ared with parameters immediately after implant, parame-
ers immediately after implant with 6-month follow-up
ata, and 6-month follow-up data with the interruption
arameters. Therefore, to adjust for inflation of the type I
rror with multiple tests, we applied a Bonferroni correction
nd considered a p value of 0.017 (0.05/3) to be statisti-
ally significant.
esults
atients. Baseline characteristics of the 25 patients (16
en, age 68 10 years) are summarized in Table 1. A total
f 19 patients (76%) had moderate MR, and 6 patients
14%) had severe MR before CRT implantation. Speckle
racking radial strain analysis showed that dyssynchrony
etween the anterior and posterior papillary muscle was
resent in all patients (169  69 ms, range 92 to 254 ms).
n 18 patients (72%), the APM was located adjacent to the
ateral LV segment, and adjacent to the anterior LV
egment in the remaining patients (28%) (Fig. 2). Further-
ore, the PPM was located adjacent to the inferior LV
egment in 22 patients (88%) and adjacent to the posterior
V segment in 3 patients (12%).
Device implantation was successful in all patients, and no
atient Characteristics (n  25)
Table 1 Patient Characteristics (n  25)
Age (yrs) 68  10
Gender (male/female) 16/9
NYHA functional class (III/IV) 24/1
Ischemic etiology 16 (64%)
QRS duration (ms) 154  25
LBBB 20 (80%)
Sinus rhythm/atrial fibrillation/paced 21/1/3
Severity of MR (moderate/severe) 19/6
LV end-systolic volume (ml) 196  85
LV end-diastolic volume (ml) 251  85
LV ejection fraction (%) 23  8
APM-PPM dyssynchrony (ms) 169  69
Medication
Anticoagulants 24 (96%)
Diuretics 23 (92%)
ACE inhibitors 22 (88%)
Beta-blockers 20 (80%)
Spironolactone 14 (56%)
CE  angiotensin-converting enzyme; APM-PPM dyssynchrony  dyssynchrony between the
nterior and posterior papillary muscles; LBBB  left bundle branch block; LV  left ventricular;
R  mitral regurgitation; NYHA  New York Heart Association.rocedure-related complications were observed. One patient
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Reduction in MR After CRT November 20, 2007:2071–7ied of worsening heart failure before the 6-month
ollow-up evaluation.
hanges in MR, mitral deformation indexes, and LV
unction. According to the inclusion criteria, all patients
howed an immediate reduction in severity of MR after
RT; vena contracta width decreased from 0.54  0.15 cm
o 0.39  0.13 cm (p  0.001). Importantly, this reduction
n MR was maintained at 6 months’ follow-up (vena
ontracta width 0.37  0.11 cm; p  NS vs. immediately
fter CRT), followed by an immediate increase of MR when
he pacemaker was turned off at 6 months (Table 2, Fig. 3).
Figure 3 Severity of Mitral Regurgitation After CRT
Severity of mitral regurgitation (expressed in mean vena contracta width) at
baseline (PRE), immediately after CRT implantation (POST), at 6 months’
follow-up (6 MO), and during interruption of CRT at 6 months (OFF). CRT  car-
diac resynchronization therapy.
chocardiographic Parameters at PRE, POST, 6 MO, and OFF
Table 2 Echocardiographic Parameters at PRE, POST, 6 MO, a
PRE POST 6 MO
Severity in MR
None/mild/moderate/severe 0/0/19/6 0/10/15/0 3/8/13
Vena contracta width (cm) 0.54 0.15 0.39 0.13 0.37 0
Jet area (cm2) 7.7 3.1 4.6 2.4 4.1 2
Jet area/LA area (%) 40 13 25 11 25 1
LV dP/dt (mm Hg) 702 344 1153 620 1160 6
LV remodeling
LV end-systolic volume (ml) 196 85 183 85 145 8
LV end-diastolic volume (ml) 251 85 249 87 205 9
LV ejection fraction (%) 23 8 28 9 33 1
PPM-fibrosa (cm) 6.7 0.5 6.4 0.6 6.1 0
Mitral deformation indexes
Tenting area (cm2) 7.8 1.0 7.2 1.0 6.7 1
Coaptation height (cm) 1.94 0.28 1.84 0.17 1.79 0
MA contraction (%) 15 4 19 4 22 4
Dyssynchrony
APM-PPM dyssynchrony (ms) 169 69 25 26 26 2
Bonferroni correction: A p value of 0.017 was considered to be statistically significant.
6 MO at 6months’ follow-up; CRT cardiac resynchronization therapy; dP/dtmaximal rate o
f cardiac resynchronization therapy at 6 months’ follow-up; POST immediately after cardiac resy
nd the intervalvular fibrosa; PRE  baseline; other abbreviations as in Table 1.vThe acute improvement in MR after CRT implantation
as accompanied by an immediate improvement in LV
P/dt, a reduction in LV end-systolic volume, and a
eterioration of LV function. The LV end-diastolic volume
id not change acutely. At 6 months’ follow-up, the
mprovement in LV volumes and LV function was even
ore pronounced, with evidence of significant LV reverse
emodeling. An acute deterioration of these parameters,
xcept for LV end-diastolic volume, occurred during inter-
uption of CRT at 6 months’ follow-up.
Furthermore, acute local remodeling after initiation of
RT was noted, as demonstrated by an acute reduction in
PM-fibrosa distance from 6.7  0.5 cm to 6.4  0.6 cm
p  0.001), with a further reduction to 6.1  0.6 cm at
months’ follow-up (p  0.004 vs. after CRT initiation).
Finally, acute reduction in MR was accompanied by an
cute improvement in mitral deformation indexes. An acute
mprovement in tenting area was observed (from 7.8  1.0
m2 to 7.2  1.0 cm2; p  0.001), with reduction in
oaptation height (from 1.94 0.18 cm to 1.79 0.14 cm;
 0.001) and improvement in mitral annular contraction
from 16  4% to 20  4%; p  0.001). This improvement
as maintained or even further improved after 6 months of
RT, followed by an acute deterioration of these parame-
ers after interruption of CRT.
hanges in dyssynchrony between the papillary muscles.
peckle tracking analysis was possible in all patients; how-
ver, 31 of the 588 evaluated segments (5%) had to be
liminated because of negative strain values. In case of very
ow but positive strain values the segment was included
hen appearing hypokinetic or dyskinetic on the short-axis
F
OFF
p Value,
PRE vs. POST*
p Value,
POST vs. 6 MO*
p Value,
6 MO vs. OFF*
2/2/17/3 0.001 1.0 0.001
0.47 0.16 0.001 0.57 0.003
6.5 3.2 0.001 0.33 0.001
39 13 0.001 0.96 0.001
847 517 0.001 0.68 0.002
163 88 0.001 0.001 0.001
210 101 0.51 0.001 0.17
29 10 0.001 0.006 0.001
6.3 0.6 0.001 0.004 0.001
6.9 1.3 0.001 0.002 0.001
1.84 0.18 0.001 0.23 0.001
19 5 0.001 0.017 0.009
134 51 0.001 0.91 0.001
ntricular systolic pressure increase; LA left atrial; MAmitral annular; OFF during interruption
ization therapy implantation; PPM-fibrosa distance between the posterior papillary muscle headnd OF
/0
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November 20, 2007:2071–7 Reduction in MR After CRTInitiation of CRT exhibited resynchronization of the
apillary muscles as demonstrated by a decrease in APM-
PM dyssynchrony from 169  69 ms to 25  26 ms (p 
.001) (Fig. 4). This reduction in dyssynchrony was main-
ained at 6 months’ follow-up (25  26 ms immediately
fter CRT vs. 26 28 ms at 6 months’ follow-up; pNS).
owever, during interruption of CRT, APM-PPM dyssyn-
hrony increased acutely to 134  51 ms (Fig. 5).
linical evaluation at 6 months’ follow-up. After 6
onths of CRT, 18 patients improved 1 NYHA functional
lass and 3 patients improved 2 NYHA functional classes
p  0.001). The quality-of-life score decreased from 35 
7 to 19  14 (p  0.001). In addition, a significant
ncrease in 6-min walking distance was noted (from 296 
01 m to 395  95 m; p  0.001).
atients without reduction of MR after CRT. Of note,
nalysis of the 38 patients who did not show an imme-
iate reduction in MR severity after CRT revealed that
hese patients had minimal APM-PPM dyssynchrony at
aseline compared with the patients who did show an
mmediate reduction after CRT initiation (38  55 ms
s. 169  69 ms; p  0.001).
iscussion
he results of the present study illustrate that the mecha-
ism underlying acute improvement in MR after CRT may
e attributable to resynchronized contraction of the papil-
ary muscles. Interruption of CRT at 6 months’ follow-up
esulted in acute loss of APM-PPM resynchronization with
n acute deterioration of MR. Furthermore, the acute
mprovement in MR was accompanied by an improvement
n mitral deformation indexes, whereas CRT interruption at
months’ follow-up was associated with an acute deterio-
ation of these parameters.
RT and reduction in MR. As demonstrated in various
andomized trials, CRT in patients with moderate-to-
evere heart failure results in a sustained improvement in
ymptoms and LV systolic function and reverse remodeling
17–21). Furthermore, CRT may also reduce MR (19,21–
4). For instance, the MIRACLE (Multicenter InSync
andomized Clinical Evaluation) trial reported a significant
eduction in MR in the CRT group after 6 months (MR jet
rea decreased from 7.31 6.14 cm2 to 4.81 cm2; p 0.01)
21). This reduction in MR has been attributed to LV
everse remodeling, with a secondary reduction in mitral
nnular diameter and as a consequence restored mitral valve
losure, which is a long-term effect of CRT.
However, other studies reported an immediate improve-
ent in MR severity after CRT initiation. Breithardt et al.
1) studied 24 heart failure patients (LV ejection fraction
1  6%) and demonstrated that the severity of MR
mproved immediately after CRT, with a reduction in
ffective regurgitant orifice area from 25  19 mm2 to 13 
mm2 (p 0.01). A similar acute reduction in MR severity
as demonstrated by Kanzaki et al. (2); the regurgitant 0olume decreased from 40  20 ml to 24  17 ml (p 
.01) (2). In line with these results, the present study
howed an immediate reduction in MR severity after CRT
n all patients (vena contracta width from 0.54 0.15 cm to
Figure 4 Patient Example
Time-strain curves of the 6 left ventricle (LV) segments at the level of the papil-
lary muscles. (A) At baseline, the delay between peak radial strain of the
anterior papillary muscle (adjacent to the lateral LV segment; green curve)
and the posterior papillary muscle (adjacent to the inferior LV segment;
dark blue curve) was 180 ms. (B) After initiation of CRT, the dyssynchrony
between the papillary muscles disappeared..39  0.13 cm; p  0.001). This improvement was
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Reduction in MR After CRT November 20, 2007:2071–7ccompanied by a significant decrease in LV end-systolic
olume and an increase in LV dP/dt and LV function
imilar to those of the earlier studies (1,2). Furthermore, as
hown in Table 2, mitral deformation indexes and local LV
emodeling showed an acute improvement after CRT.
elation between MR and dyssynchrony. Preliminary
esults suggested that the immediate reduction in MR may
e caused by resynchronization of the papillary muscles (2).
urthermore, increased closing force of the mitral leaflets
ay also be important for the improvement in MR (1). The
resent findings further support this hypothesis.
First, LV dP/dt almost doubled after CRT initiation
702  344 mm Hg to 1,153  620 mm Hg; p  0.001),
ith an improvement in LV ejection fraction (from 23 
% to 28  9%, p  0.001), which effectively counteracts
he increased tethering forces (with a decrease in tenting
rea from 7.8  1.0 mm2 to 7.2  1.0 mm2; p  0.001).
reithardt et al. (1) showed a somewhat similar increase in
V dP/dt acutely after CRT.
Furthermore, all 25 included patients showed an imme-
iate reduction in APM-PPM dyssynchrony (from 169 
9 ms to 25  26 ms; p  0.001) accompanied by a
eduction in MR severity. A similar reduction in time delay
etween the papillary muscles after CRT initiation was
emonstrated by Kanzaki et al. (2) (106  74 ms to 39 
3 ms; p  0.001), who evaluated 26 heart failure patients
LV ejection fraction 24  6%, 73% ischemic cardiomyop-
thy) with at least mild MR before and after CRT using
echanical activation strain maps.
Importantly, assuming that the improvement in MR is
iventricular pacing dependent, it could be anticipated that
nterruption of biventricular pacing would lead to an imme-
iate desynchronization of the papillary muscles with acute
eterioration of MR. Indeed, all acute improvements in
chocardiographic parameters were maintained or more
mproved during follow-up; in particular, MR severity (vena
Figure 5 Papillary Muscle Dyssynchrony After CRT
Dyssynchrony between the papillary muscles at PRE,
POST, 6 MO, and OFF. Abbreviations as in Figures 1 and 3.ontracta width 0.39  0.13 cm after CRT to 0.37  0.11m after 6 months; p  NS) and dyssynchrony between the
apillary muscles (25  26 ms to 26  28 ms; p  NS)
howed no changes. During interruption of biventricular
acing, however, both MR severity and dyssynchrony
howed an acute worsening of mitral deformation indexes
nd parameters, reflecting global and local remodeling.
randt et al. (25) focused specifically on the hemodynamic
onsequences of temporary interruption of CRT in 20
atients after a median duration of biventricular pacing of
27 days and demonstrated similar results: withdrawal of
RT resulted in a decline in LV dP/dt and an increase in
R (median MR jet area from 4.1 to 5.9 mm2; p  0.002).
owever, markers of dyssynchrony were not reported in
hat study.
linical implications. Given the rapid increase in patients
ith dilated cardiomyopathy and secondary MR, on the one
and, and the poor survival of these patients on the other
and, treatment of MR is an important issue (26–28). At
resent, surgical valve repair or replacement is the therapy of
hoice, but surgery is associated with relatively high risk for
erioperative morbidity and mortality, and alternative treat-
ent options are considered in patients who are not
menable for surgery (29,30). In this perspective, the find-
ngs of the current study are relevant, because these obser-
ations suggest that CRT may be considered as a potential
lternative treatment of MR in patients who cannot un-
ergo surgery. In particular, CRT may reduce MR if
yssynchrony involves the posterior papillary muscle.
Still, it is important to emphasize that the present
atients represent a highly selected cohort; 60% of patients
ith baseline MR did not show an acute improvement in
R. Importantly, however, these patients without an acute
eduction in MR after CRT initiation had minimal APM-
PM dyssynchrony. Future prospective studies are needed
o further elucidate the relation between LV dyssynchrony
nd reduction in MR after CRT.
onclusions
ardiac resynchronization therapy can acutely reduce MR
n patients with dyssynchrony involving the papillary mus-
les; interruption of CRT at 6 months’ follow-up, however,
esulted in acute loss of resynchronization with recurrence
f MR.
eprint requests and correspondence: Dr. Jeroen J. Bax, Depart-
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